These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 28716573
1. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer. Forse CL, Rahimi M, Diamandis EP, Assarzadegan N, Dawson H, Grin A, Kennedy E, O'Connor B, Messenger DE, Riddell RH, Kirsch R, Karagiannis GS. Exp Mol Pathol; 2017 Aug; 103(1):94-100. PubMed ID: 28716573 [Abstract] [Full Text] [Related]
2. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition. Yamada N, Sugai T, Eizuka M, Tsuchida K, Sugimoto R, Mue Y, Suzuki M, Osakabe M, Uesugi N, Ishida K, Otsuka K, Matsumoto T. Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787 [Abstract] [Full Text] [Related]
3. High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non-small-cell lung cancer. Zhao J, Zhang J, Zhang X, Feng M, Qu J. Oncotarget; 2016 Jun 28; 7(26):40725-40734. PubMed ID: 27166271 [Abstract] [Full Text] [Related]
5. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer. Sandberg TP, Stuart MPME, Oosting J, Tollenaar RAEM, Sier CFM, Mesker WE. BMC Cancer; 2019 Mar 29; 19(1):284. PubMed ID: 30922247 [Abstract] [Full Text] [Related]
6. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status. Kevans D, Wang LM, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J. Int J Surg Pathol; 2011 Dec 29; 19(6):751-60. PubMed ID: 21791486 [Abstract] [Full Text] [Related]
18. A Pan-Cancer Analysis to Provide Insight into the Immunological Role and Prognostic Value of HTRA3. Xu Q, Wang J, Wang J, Zhu Y, Chen B, Guo R, Qian Y, Yuan H, Liu F. Crit Rev Eukaryot Gene Expr; 2023 Jan 29; 33(8):57-75. PubMed ID: 37606164 [Abstract] [Full Text] [Related]
20. Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study. Koelzer VH, Herrmann P, Zlobec I, Karamitopoulou E, Lugli A, Stein U. BMC Cancer; 2015 Mar 21; 15():160. PubMed ID: 25884643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]